SKBA Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
SKBA Capital Management's PFE Position: Q1 2026 in Review
SKBA Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 495,750 shares worth $13.9M. The position accounts for 1.91% of the portfolio, ranked #21.
SKBA Capital Management first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $14.4M in Q1 2014. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- SKBA Capital Management held 495,750 shares of Pfizer worth $13.9M as of Q1 2026.
- SKBA Capital Management left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 1.91% of SKBA Capital Management's portfolio in Q1 2026, its #21 holding.
- SKBA Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
- SKBA Capital Management's Pfizer position peaked at $14.4M in Q1 2014.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.